drugset / Trial / NCT00268554

Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole

NCT00268554

Completed 12 enrolled Radboud University Medical Center
Non-randomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine whether dipyridamole enhances postocclusive reactive hyperaemia by increasing extracellular adenosine concentrations during ischemia and reperfusion. Furthermore we hypothesize that dipyridamole augments postocclusive reactive hyperaemia by increasing adenosine receptor stimulation.

Timeline

Start
2005-12
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule
Subject Dipyridamole Other / unclassified

Indications

No indication recorded.